Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Former Sen. Ben Sasse (R-Neb.) detailed his battle with cancer and reflected on his life during a wide-ranging interview with The New York Times’s Ross Douthat. The conversation, released Thursday as ...

Raphael was believed to be 17 when he did this chalk sketch, likely a self-portrait. "What is really extraordinary is the perfection of his technique in drawing," said curator Carmen Bambach. You can ...

The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...

CLEVELAND, Ohio — Pancreatic cancer stands apart from many common cancers for a troubling reason: There is no standard screening test to catch the disease early, when treatment is most effective. That ...

A quick and easy breath test could mean new hope in the early detection of pancreatic cancer, and medical experts say it could be the biggest breakthrough in the fight against the deadly disease in ...

If you have type 1 diabetes, you may have wondered if a pancreas transplant could cure your condition. In fact, for a select group of people with advanced complications, a pancreas transplant may be ...

Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...